First Time Loading...

Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.12 USD -0.22% Market Closed
Updated: Apr 28, 2024

Theravance Biopharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theravance Biopharma Inc
Revenue Peer Comparison

Comparables:

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Theravance Biopharma Inc
NASDAQ:TBPH
Revenue
$57.4m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
76%

Theravance Biopharma Inc
Revenue Breakdown

Breakdown by Geography
Theravance Biopharma Inc

Total Revenue: 57.4m USD
100%
United States: 57.2m USD
99.6%
Europe: 223k USD
0.4%

Breakdown by Segments
Theravance Biopharma Inc

Not Available

See Also

What is Theravance Biopharma Inc's Revenue?
Revenue
57.4m USD

Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Revenue amounts to 57.4m USD.

What is Theravance Biopharma Inc's Revenue growth rate?
Revenue CAGR 10Y
76%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Theravance Biopharma Inc have been -7% over the past three years , -1% over the past five years , and 76% over the past ten years .